Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Understand the step-by-step process of refinancing with a concise overview of what happens at each stage.
15,155 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Costco stock climbs this year on a blend of defensive growth and stronger e commerce. Analysts say the setup could sp...
SoundHound AI stock has pulled back from its peak, leaving investors wondering if a bargain is in play. This guide br...
DBA closed $68 million for its second venture fund on Feb. 18, 2026, signaling sustained appetite for crypto infrastr...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
A fresh AI marketing platform is launching via Reg A+ at 0.85 per share, aiming to deliver rapid ROI for large brands...
A rapid shift is redefining tech leadership along a coastal corridor from NYC to Miami. The next great american tech ...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...